Their technology is nowhere near ready. They have
Post# of 72440
There is NO way that a technology like this would be approved to use with Brilacidin when there isn't even a completed Phase 2. The powder formulation would have to be engineered for Brilacidin, and you can bet that they will want safety testing before using a powder form of a drug in people who are ill with lung infection and inflammation. This would be a long process.
If Brilacidin were to be used in some kind of inhaled form, it sure won't be this one in the near future, by which I mean by the end of 2020.